Riociguat

Details

Files

Generic Name:

Riociguat

Project Status:

Complete

Therapeutic Area:

Chronic thromboembolic pulmonary hypertension

Manufacturer:

Bayer Inc.

Call for patient/clinician input open:

September 12, 2013

Brand Name:

Adempas

Project Line:

Reimbursement Review

Project Number:

SR0353-000

Call for patient/clinician input closed:

October 22, 2013

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Pulmonary hypertension, chronic thromboembolic

Recommendation Type:

List with criteria/condition

Final Recommendation:

July 17, 2014

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Last Updated : September 30, 2013